Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
55
NCT00161707
Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
Phase: Phase 1/2
Role: Collaborator
Start: Jan 7, 2003
Completion: Oct 1, 2003
NCT00157092
Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
Start: Mar 1, 2004
Completion: Oct 14, 2004